Skip to main content
. 2023 Dec 8;36:e1783. doi: 10.1590/0102-672020230065e1783

Table 2. Intraoperative details and short-term outcomes.

RDP
(n=29)
LDP
(n=30)
p
Operative time (minutes) 224±54 213±49 0.36
Conversion to open procedure n (%) 1 (3.4) 2 (6.7) 1.00
Blood transfusion n (%) 0 1 (3.4) 1.00
Spleen preservation n (%) 0 2 (6.7) 0.492
Parenchyma transection
with stapler n (%)
24 (82.8) 23 (76.7) 0.56
Overall morbidity n (%) 21 (72.4) 24 (80) 0.49
Clavien-Dindo n (%)
1 17 (58.6) 16 (53.3) 0.091
2 3 (10.3) 7 (23.3)
3 1 (3.4) 1 (3.3)
Pancreatic fistula 21 (72.4) 24 (80) 0.493
B 20 (69) 23 (76.7)
C 1 (3.4) 1 (3.3)
Fistula/Infectious complications 4 (13.8) 7 (23.2) 0.384
Reoperations, n (%) 1 (3.4) 1 (3.3) 1
Readmission, n (%) 3 (10.3) 4 (13.3) 1
Lenght of stay in day 6.6±1.6 7.2±3.4 0.94
Diagnosis, n (%)
PNET 10 (34,5) 18 (60)
SCN 2 (6.9) 1 (3.3)
MCN 8 (27.6) 4 (13.3)
IPMN 6 (20.7) 4 (13.3)
Other* 3 (10.3) 3 (10)
Tumor size (cm) 3.58±2.4 3.77±2.51 0.94
Lymph nodes resected 9.8±7.8 11.3±6.8 0.338

RDP: robotic distal pancreatectomy; LDP: laparoscopic distal pancreatectomy; PNET: pancreatic neuroendocrine tumor; SCN: Serous Cystic Neoplasia; MCN: Mucinous Cystic Neoplasia; IPMN: Intraductal P apillary Mucinous Neoplasm; *benign cyst, solitary fibrous tumor, desmoid tumor, solid pseudopapillary pancreatic tumor.